Advertisement

Infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy

Joshua A. Hill, Daniel Li, Kevin A. Hay, Margaret L. Green, Sindhu Cherian, Xueyan Chen, Stanley R. Riddell, David G. Maloney, Michael Boeckh and Cameron J. Turtle

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted July 13, 2017
  • Accepted October 8, 2017
  • Published online October 16, 2017.

Article Versions


Contributors 
  • Joshua A. Hill, 1 Department of Medicine, University of Washington, Seattle, WA, United States;
  • Daniel Li, 2 Juno Therapeutics, Seattle, WA, United States;
  • Kevin A. Hay, 3 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Margaret L. Green, 4 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Sindhu Cherian, 5 Department of Laboratory Medicine, University of Washington, Seattle, WA, United States
  • Xueyan Chen, 5 Department of Laboratory Medicine, University of Washington, Seattle, WA, United States
  • Stanley R. Riddell, 3 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • David G. Maloney, 3 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Michael Boeckh, 4 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Cameron J. Turtle, 3 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output